XKRX
035810
Market cap214mUSD
Oct 08, Last price
4,460.00KRW
1D
-0.56%
1Q
1.36%
Jan 2017
-27.36%
Name
Easy Holdings Co Ltd
Chart & performance
P/E
10.75
P/S
0.08
EPS
414.82
Div yield, %
—
Shrs. gr., 5y
2.72%
Rev. gr., 5y
16.07%
Revenues
3.39t
+3.16%
Net income
26.76b
+57.30%
CFO
236.40b
+43.40%
Dividend
Mar 09, 20261361 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
EASY HOLDINGS Co., Ltd. is a South Korean enterprise established in 1988, based in Seoul, operating within the biological resource industry. The company specializes in producing and distributing natural substitutes for antibiotics, environmental improvement agents, and microbial testing kits. Its portfolio extends to supplying agricultural and livestock food products, alongside various feed additives. Furthermore, EASY HOLDINGS is actively engaged in biotechnology, feed solutions, and agro-livestock infrastructure projects, as well as the provision of processed meat items and diverse investment activities.
Key people
Yil Hwan Hwang
Co-Chief Executive Officer, Director · since 2018
Ji Beom Kim
Co-Chief Executive Officer, Director · since 2011
Chung Seok Kim
Vice President · since 2012
Tae Yil Oh
Internal Auditor
Co-Chief Executive Officer, Director · since 2017
Non-Executive Independent Director · since 2006
Sang Cheol Kim
Non-Executive Independent Director · since 2024
Headquarters & legal address
서울특별시 강남구 강남대로 310, 유니온센터오피스텔 3층 (역삼동)
301호
Seoul, 11 06253
KR
301호
Seoul, 11 06253
KR
Address
gang-nam daero 310, gang-nam gu, seoul, korea
3th floor
Seoul, 11 06253
KR
3th floor
Seoul, 11 06253
KR
Other language
EASY BIO Inc.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||